Advertisement

Topics

Consort Medical plc CSRT Financial and Strategic SWOT Analysis Review [Report Updated: 01082017] Prices from USD $125

15:33 EDT 19 Aug 2017 | BioPortfolio Reports

Consort Medical plc CSRT Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.
Corporate strategy Analyst's summarization of the company's business strategy.
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.

Highlights

Consort Medical plc Consort Medical is a global contract development and manufacturing organization CDMO with focus on medical device technologies for drug delivery. It develops, manufactures and markets high volume disposable medical devices for drug delivery and pointofcare POC diagnostics. It offers metered dose inhalers, dry powder devices, actuators, dose counters, disposable autoinjectors, nasal devices and POC diagnostic devices. The company provides inhaler and autoinjector technologies and manufacturing services to pharmaceutical manufacturers; and active pharmaceutical ingredients API, and finished dose formulation and manufacturing services. The company offers its products to pharmaceutical companies in the US, Europe, and other parts of the world through its subsidiaries and distributors. Consort Medical is headquartered in Hertfordshire, England, the UK

Consort Medical plc Key Recent Developments

Jun 15,2017: Consort Medical: Full year results
Dec 14,2016: Consort Medical: Directorate Change
Dec 06,2016: Consort Medical Reports Interim Results Results For The Six Months Ended 31 October 2016
Dec 05,2016: Vitec FD takes Consort Medical CFO role
Nov 25,2016: Consort Medical: CFO Appointment

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Consort Medical plc CSRT Financial and Strategic SWOT Analysis Review [Report Updated: 01082017] Prices from USD $125

NEXT ARTICLE

More From BioPortfolio on "Consort Medical plc CSRT Financial and Strategic SWOT Analysis Review [Report Updated: 01082017] Prices from USD $125"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...

Asthma
Asthma is caused by inflammation of small tubes, called bronchi, which carry air in and out of the lungs. If you have asthma, the bronchi will be inflamed and more sensitive than normal.  When you come into contact with something that irritates your...